Doctor of Philosophy / Department of Biology / Kristin Michel / Malaria remains a major human vector-borne disease, greatly contributing to global human morbidity and mortality. Control of mosquito vectors that transmit malaria continues to be dependent on the widespread application of chemical insecticides through indoor residual spraying and insecticide treated bed nets. However, resistance to these insecticides is spreading within many mosquito populations, adding an ever-increasing urgency to the development of alternative vector control measures. The mosquito immune system is a potential novel target for such alternative measures, as the immune response initiated in these insects during infection with vector-borne disease agents is a key determinant of vector competence and, thus, contributes to a species’ vectorial capacity. These immune responses, additionally, interact with and respond to parasitic or symbiotic biocontrol agents employed to kill or manipulate infection outcome with vector-borne disease agents. Entomopathogenic fungi, including Beauveria bassiana, have been considered as an alternative vector control measure, functioning as biopesticides. The Toll pathway is a key antifungal immune pathway in insects that impacts an insect’s ability to survive fungal infections. A better understanding of Toll signaling immune function and evolution in anophelines, both vector and nonvector, can thus help to improve future biocontrol methods of important vector mosquitoes like Anopheles gambiae. In this dissertation, I report the use of B. bassiana strain I93-825 in An. gambiae to analyze the impact of Toll pathway modulation on mosquito survival. Mosquito survivorship was strongly affected by B. bassiana exposure dose by several measured parameters including median survival, longevity, and hazard. Modulation of Toll signaling, by way of knockdown by RNA interference, revealed a dose-dependent trade-off between immune activation state and survivorship in An. gambiae. To better determine the full Toll immune signaling repertoire in mosquitoes, I annotated and describe the evolutionary history of intracellular Toll pathway members and Toll-like receptors (TLRs) within 21 mosquito genomes. The intracellular signaling pathway is conserved with 1:1 orthology, and evolutionary rates across different intracellular pathway members vary widely as compared to the conserved protein core of these mosquito species. In contrast, TLRs evolved largely by duplication events within certain anopheline lineages, most dramatically in the An. gambiae complex, where six TOLL1/5 paralogs likely possess different ligand binding specificities. Thus, these TLRs should be prioritized for experimental analyses of TLR immune function in An. gambiae. Taken together, the work in this dissertation identifies Toll pathway modulation as a potential resistance mechanism that could impact malaria biocontrol strategies and provides a foundation for future detailed studies of Toll pathway function in important mosquito vector species.

No description available.

During the last 40 years, Drosophila melanogaster has become an invaluable tool in understanding innate immunity. The innate immune system of Drosophila consists of a humoral and a cellular component. While many details are known about the humoral immune system, our knowledge about the cellular immune system is comparatively small. Blood cells or hemocytes constitute the cellular immune system. Three blood types have been described for Drosophila larvae. Plasmatocytes are phagocytes with a plethora of functions. Crystal cells mediate melanization and contribute to wound healing. Plasmatocytes and crystal cells constitute the blood cell repertoire of a healthy larva, whereas lamellocytes are induced in a demand-adapted manner after infection with parasitoid wasp eggs. They are involved in the melanotic encapsulation response against parasites and form melanotic nodules that are also referred to as tumors. In my thesis, I focused on unraveling the mechanisms of how the immune system orchestrates the cellular immune response. In particular, I was interested in the hematopoiesis of lamellocytes. In Article I, we were able to show that ectopic expression of key components of a number of signaling pathways in blood cells induced the development of lamellocytes, led to a proliferative response of plasmatocytes, or to a combination of lamellocyte activation and plasmatocyte proliferation. In Article II, I combined newly developed fluorescent enhancer-reporter constructs specific for plasmatocytes and lamellocytes and developed a “dual reporter system” that was used in live microscopy of fly larvae. In addition, we established flow cytometry as a tool to count total blood cell numbers and to distinguish between different blood cell types. The “dual reporter system” enabled us to differentiate between six blood cell types and established proliferation as a central feature of the cellular immune response. The combination flow cytometry and live imaging increased our understanding of the tempo-spatial events leading to the cellular immune reaction. In Article III, I developed a genetic modifier screen to find genes involved in the hematopoiesis of lamellocytes. I took advantage of the gain-of-function phenotype of the Tl10b mutation characterized by an activated cellular immune system, which induced the formation blood cell tumors. We screened the right arm of chromosome 3 for enhancers and suppressors of this mutation and uncovered ird1. Finally in Article IV, we showed that the activity of the Toll signaling pathway in the fat body, the homolog of the liver, is necessary to activate the cellular immune system and induce lamellocyte hematopoiesis.